These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6720233)

  • 1. Antidiuretic effect of perorally administered DDAVP in hydrated humans.
    Vilhardt H; Bie P
    Acta Endocrinol (Copenh); 1984 Apr; 105(4):474-6. PubMed ID: 6720233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antidiuretic reaction of the human and rat kidney to peroral administration of arginine-vasopressin and desmopressin].
    Natochin IuV; Grigor'ev AI; Buravkova LB; Larina IM; Prutskova NP; Shakhmatova EI
    Ross Fiziol Zh Im I M Sechenova; 2003 Feb; 89(2):184-92. PubMed ID: 12710188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
    Radó JP; Marosi J; Fischer J; Takó J; Kiss N
    Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.
    Williams TD; Dunger DB; Lyon CC; Lewis RJ; Taylor F; Lightman SL
    J Clin Endocrinol Metab; 1986 Jul; 63(1):129-32. PubMed ID: 3711257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.
    Matsui K; Kimura T; Ota K; Iitake K; Shoji M; Inoue M; Yoshinaga K
    Endocrinol Jpn; 1985 Aug; 32(4):547-57. PubMed ID: 3936702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiuretic responses to injected desmopressin, alone and with indomethacin.
    Moses AM; Moses LK; Notman DD; Springer J
    J Clin Endocrinol Metab; 1981 May; 52(5):910-3. PubMed ID: 7228994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of three specific radioimmunoassays in measuring neurohypophysial hormone content and plasma concentrations of vasopressin, oxytocin and DDAVP in rats after prolonged infusion of DDAVP.
    Lundin S; Melin P; Vilhardt H
    Experientia; 1985 Jul; 41(7):933-5. PubMed ID: 4007132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of two analogues of arginine-vasopressin (ornithine-vasopressin and desamino-D-arginine-vasopressin) on kidney function in sheep.
    Yesberg NE; Henderson M; Budtz-Olsen OE
    Q J Exp Physiol Cogn Med Sci; 1978 Apr; 63(2):179-88. PubMed ID: 247535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of oligohydramnios with maternal 1-deamino-[8-D-arginine] vasopressin-induced plasma hypoosmolality.
    Ross MG; Cedars L; Nijland MJ; Ogundipe A
    Am J Obstet Gynecol; 1996 May; 174(5):1608-13. PubMed ID: 9065138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the antidiuretic effect of 1-deamino-8d-arginine vasopressin (DDAVP) by glibenclamide in water-loaded healthy subjects.
    Radó JP; Borbély L
    Endokrinologie; 1975 Sep; 66(1):88-93. PubMed ID: 817889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effect and plasma concentrations of DDAVP after intranasal and peroral administration to humans.
    Vilhardt H; Lundin S
    Gen Pharmacol; 1986; 17(4):481-3. PubMed ID: 3758654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased PGE2 excretion by dDAVP in humans depends on state of hydration.
    Schwertschlag U; Gerber JG; Barnes JS; Nies AS
    Am J Physiol; 1986 Jun; 250(6 Pt 2):F1008-12. PubMed ID: 3459369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraamniotic deamino(D-Arg8)-vasopressin: prolonged effects on ovine fetal urine flow and swallowing.
    Kullama LK; Nijland MJ; Ervin MG; Ross MG
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):78-84. PubMed ID: 8572038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antidiuretic therapy: studies in the diabetes insipidus rat.
    Kinter LB; Beeuwkes R
    Am J Physiol; 1982 Nov; 243(5):R491-9. PubMed ID: 7137378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
    Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the antidiuretic response of kidneys to different modes of vasopressin administration].
    Grigor'ev AI; Larina IM; Buravkova LB; Goncharova AG; Dobrokhotov IV; Natochin IuV
    Fiziol Cheloveka; 2003; 29(3):89-97. PubMed ID: 12845788
    [No Abstract]   [Full Text] [Related]  

  • 18. DDAVP-induced maternal hyposmolality increases ovine fetal urine flow.
    Nijland MJ; Ross MG; Kullama LK; Bradley K; Ervin MG
    Am J Physiol; 1995 Feb; 268(2 Pt 2):R358-65. PubMed ID: 7864229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Deamino-[8-D-arginine] vasopressin-induced maternal plasma hypoosmolality increases ovine amniotic fluid volume.
    Ross MG; Nijland MJ; Kullama LK
    Am J Obstet Gynecol; 1996 Apr; 174(4):1118-25; discussion 1125-7. PubMed ID: 8623838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
    Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
    Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.